Literature DB >> 25625347

Corticosterone alters materno-fetal glucose partitioning and insulin signalling in pregnant mice.

O R Vaughan1, H M Fisher, K N Dionelis, E C Jeffreys, J S Higgins, B Musial, A N Sferruzzi-Perri, A L Fowden.   

Abstract

Glucocorticoids affect glucose metabolism in adults and fetuses, although their effects on materno-fetal glucose partitioning remain unknown. The present study measured maternal hepatic glucose handling and placental glucose transport together with insulin signalling in these tissues in mice drinking corticosterone either from day (D) 11 to D16 or D14 to D19 of pregnancy (term = D21). On the final day of administration, corticosterone-treated mice were hyperinsulinaemic (P < 0.05) but normoglycaemic compared to untreated controls. In maternal liver, there was no change in glycogen content or glucose 6-phosphatase activity but increased Slc2a2 glucose transporter expression in corticosterone-treated mice, on D16 only (P < 0.05). On D19, but not D16, transplacental (3) H-methyl-d-glucose clearance was reduced by 33% in corticosterone-treated dams (P < 0.05). However, when corticosterone-treated animals were pair-fed to control intake, aiming to prevent the corticosterone-induced increase in food consumption, (3) H-methyl-d-glucose clearance was similar to the controls. Depending upon gestational age, corticosterone treatment increased phosphorylation of the insulin-signalling proteins, protein kinase B (Akt) and glycogen synthase-kinase 3β, in maternal liver (P < 0.05) but not placenta (P > 0.05). Insulin receptor and insulin-like growth factor type I receptor abundance did not differ with treatment in either tissue. Corticosterone upregulated the stress-inducible mechanistic target of rapamycin (mTOR) suppressor, Redd1, in liver (D16 and D19) and placenta (D19), in ad libitum fed animals (P < 0.05). Concomitantly, hepatic protein content and placental weight were reduced on D19 (P < 0.05), in association with altered abundance and/or phosphorylation of signalling proteins downstream of mTOR. Taken together, the data indicate that maternal glucocorticoid excess reduces fetal growth partially by altering placental glucose transport and mTOR signalling.
© 2015 The Authors. The Journal of Physiology © 2015 The Physiological Society.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25625347      PMCID: PMC4358686          DOI: 10.1113/jphysiol.2014.287177

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  66 in total

1.  Maternal undernutrition during late gestation induces fetal overexposure to glucocorticoids and intrauterine growth retardation, and disturbs the hypothalamo-pituitary adrenal axis in the newborn rat.

Authors:  J Lesage; B Blondeau; M Grino; B Bréant; J P Dupouy
Journal:  Endocrinology       Date:  2001-05       Impact factor: 4.736

2.  Enhanced placental GLUT1 and GLUT3 expression in dexamethasone-induced fetal growth retardation.

Authors:  M L Langdown; M C Sugden
Journal:  Mol Cell Endocrinol       Date:  2001-12-20       Impact factor: 4.102

3.  Induction of obesity and hyperleptinemia by central glucocorticoid infusion in the rat.

Authors:  K E Zakrzewska; I Cusin; A Stricker-Krongrad; O Boss; D Ricquier; B Jeanrenaud; F Rohner-Jeanrenaud
Journal:  Diabetes       Date:  1999-02       Impact factor: 9.461

4.  Dexamethasone-induced intrauterine growth restriction impacts the placental prolactin family, insulin-like growth factor-II and the Akt signaling pathway.

Authors:  Rupasri Ain; Lindsey N Canham; Michael J Soares
Journal:  J Endocrinol       Date:  2005-05       Impact factor: 4.286

5.  Dexamethasone during late gestation exacerbates peripheral insulin resistance and selectively targets glucose-sensitive functions in beta cell and liver.

Authors:  M J Holness; M C Sugden
Journal:  Endocrinology       Date:  2001-09       Impact factor: 4.736

6.  Intrauterine growth restriction in humans is associated with abnormalities in placental insulin-like growth factor signaling.

Authors:  Luigi Laviola; Sebastio Perrini; Gaetana Belsanti; Annalisa Natalicchio; Carmela Montrone; Anna Leonardini; Antonella Vimercati; Marco Scioscia; Luigi Selvaggi; Riccardo Giorgino; Pantaleo Greco; Francesco Giorgino
Journal:  Endocrinology       Date:  2004-11-24       Impact factor: 4.736

7.  Serum-dependent effects of IGF-I and insulin on proliferation and invasion of human first trimester trophoblast cell models.

Authors:  M Mandl; J Haas; P Bischof; G Nöhammer; G Desoye
Journal:  Histochem Cell Biol       Date:  2002-04-16       Impact factor: 4.304

Review 8.  Prenatal glucocorticoids and long-term programming.

Authors:  Jonathan R Seckl
Journal:  Eur J Endocrinol       Date:  2004-11       Impact factor: 6.664

9.  Glucocorticoid-induced insulin resistance in skeletal muscles: defects in insulin signalling and the effects of a selective glycogen synthase kinase-3 inhibitor.

Authors:  J Ruzzin; A S Wagman; J Jensen
Journal:  Diabetologia       Date:  2005-08-03       Impact factor: 10.122

10.  Altered placental development in undernourished rats: role of maternal glucocorticoids.

Authors:  Louiza Belkacemi; Andrea Jelks; Chun-Hung Chen; Michael G Ross; Mina Desai
Journal:  Reprod Biol Endocrinol       Date:  2011-08-01       Impact factor: 5.211

View more
  22 in total

Review 1.  Placental phenotype and the insulin-like growth factors: resource allocation to fetal growth.

Authors:  Amanda N Sferruzzi-Perri; Ionel Sandovici; Miguel Constancia; Abigail L Fowden
Journal:  J Physiol       Date:  2017-05-23       Impact factor: 5.182

2.  Exercise initiated during pregnancy in rats born growth restricted alters placental mTOR and nutrient transporter expression.

Authors:  Yeukai T M Mangwiro; James S M Cuffe; Dayana Mahizir; Kristina Anevska; Sogand Gravina; Tania Romano; Karen M Moritz; Jessica F Briffa; Mary E Wlodek
Journal:  J Physiol       Date:  2019-03-01       Impact factor: 5.182

3.  Corrigendum.

Authors: 
Journal:  J Physiol       Date:  2016-06-14       Impact factor: 5.182

4.  Cortisol inhibits CSF2 and CSF3 via DNA methylation and inhibits invasion in first-trimester trophoblast cells.

Authors:  Arianna Smith; Elizabeth Witte; Devin McGee; Jason Knott; Kavita Narang; Karen Racicot
Journal:  Am J Reprod Immunol       Date:  2017-08-28       Impact factor: 3.886

Review 5.  Glucocorticoids and Reproduction: Traffic Control on the Road to Reproduction.

Authors:  Shannon Whirledge; John A Cidlowski
Journal:  Trends Endocrinol Metab       Date:  2017-03-06       Impact factor: 12.015

Review 6.  Novel roles of mechanistic target of rapamycin signaling in regulating fetal growth†.

Authors:  Madhulika B Gupta; Thomas Jansson
Journal:  Biol Reprod       Date:  2019-04-01       Impact factor: 4.285

7.  Maternal and fetal genomes interplay through phosphoinositol 3-kinase(PI3K)-p110α signaling to modify placental resource allocation.

Authors:  Amanda N Sferruzzi-Perri; Jorge López-Tello; Abigail L Fowden; Miguel Constancia
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-12       Impact factor: 11.205

8.  Glucocorticoid regulation of amino acid transport in primary human trophoblast cells.

Authors:  O R Vaughan; T L Powell; T Jansson
Journal:  J Mol Endocrinol       Date:  2019-11       Impact factor: 5.098

9.  Activation of placental insulin and mTOR signaling in a mouse model of maternal obesity associated with fetal overgrowth.

Authors:  Fredrick J Rosario; Theresa L Powell; Thomas Jansson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-10-21       Impact factor: 3.619

10.  Proximity to Delivery Alters Insulin Sensitivity and Glucose Metabolism in Pregnant Mice.

Authors:  Barbara Musial; Denise S Fernandez-Twinn; Owen R Vaughan; Susan E Ozanne; Peter Voshol; Amanda N Sferruzzi-Perri; Abigail L Fowden
Journal:  Diabetes       Date:  2016-01-06       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.